Euclidean Capital as of June 30, 2022
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 28.3 | $33M | 2.3M | 14.25 | |
| 23andme Holding Class A Com | 21.6 | $25M | 10M | 2.48 | |
| Foghorn Therapeutics (FHTX) | 14.6 | $17M | 1.3M | 13.60 | |
| Alector (ALEC) | 8.5 | $10M | 981k | 10.16 | |
| Ngm Biopharmaceuticals | 8.1 | $9.6M | 747k | 12.82 | |
| Rapt Therapeutics | 6.7 | $7.9M | 433k | 18.25 | |
| Tenaya Therapeutics (TNYA) | 4.4 | $5.2M | 916k | 5.63 | |
| First Financial Ban (FFBC) | 2.9 | $3.4M | 174k | 19.40 | |
| Oric Pharmaceuticals (ORIC) | 2.8 | $3.3M | 748k | 4.48 | |
| Surrozen | 2.0 | $2.4M | 803k | 3.00 |
